Learn More
Medchemexpress LLC NUCC-390 dihydrochloride | 2749281-71-6 | 98.2% | 468.46 | 100 MG

Supplier: Medchemexpress LLC HY111793A100MG
NUCC-390 dihydrochloride is a novel and selective small-molecule CXCR4 receptor agonist. It induces internalization of CXCR4 receptors and acts in an opposite way to AMD3100. NUCC-390 dihydrochloride promotes nerve recovery of function after neurodegeneration in vivo.
- Novel and selective small-molecule CXCR4 receptor agonist.
- Induces internalization of CXCR4 receptors.
- Acts in an opposite way of AMD3100.
- Promotes nerve recovery of function after neurodegeneration in vivo.
- Produces strong (Ca)i response (at 10 μM).
- Stimulates signaling activity downstream of CXCR4 receptors.
- Boosts axonal growth in cultured cerebellar granule neurons (CGNs) via CXCR4.
- Contributes to the functional and anatomical recovery of the neuromuscular junction (NMJ) following acute nerve terminal damage in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.